CIMB Research

Broker's Calls

After results beat, is Genting Singapore still a gamble?

SINGAPORE (Aug 3): Oh, how the wheels of fortunes have turned in favour of Genting Singapore (GENS).

Broker's Calls

Is this REIT over the hill?

SINGAPORE (Aug 1): RHB Research is downgrading Starhill Global Real Estate Investment Trust (SG REIT) to “neutral”, from “buy”, with an unchanged target price of 81 cents on the back of limited upside ahead.

Broker's Calls

Keppel Corp to seek refuge in property as O&M continues to sink

SINGAPORE (July 21): UOB Kay Hian and CIMB Research are keeping Keppel Corporation at “hold”, even as the conglomerate struggles to weather the protracted storm facing its offshore & marine (O&M) segment.

Broker's Calls

Exciting times expected ahead for ESR-REIT, says CIMB

SINGAPORE (July 14): ESR-REIT, formerly known as Cambridge Industrial Trust, has not had a lot going for it recently.

Broker's Calls

Why SembMarine is unlikely to be privatised anytime soon

SINGAPORE (July 11): CIMB Research is maintaining its “add” rating on Sembcorp Marine (SMM) with an unchanged target price of $1.88.

Broker's Calls

Why it’ll take more than an excise hike to drag ThaiBev down

SINGAPORE (July 7): CIMB Research is maintaining its “add” recommendation on Thai Beverage (ThaiBev) with an unchanged target price of $1.07.

Broker's Calls

Switch out of SIA Engineering into ST Engineering, recommends CIMB

SINGAPORE (June 28): CIMB Research is downgrading SIA Engineering from "hold" to “reduce” with a lower price target of $3.86 in view of the stock’s expensive valuations and limited catalysts.

Broker's Calls

Share swap deal to have positive impact on UOL Group

SINGAPORE (June 27): OCBC Investment Research and CIMB Research are positive on news of UOL group’s share swap deal with Haw Par Corp, through which UOL will issue 27.3 million new shares in exchange for 60 million UIC shares owned by Haw Par.

Broker's Calls

Raffles Medical share price could fall even further, says CIMB

SINGAPORE (June 20): CIMB Research is keeping its “reduce” rating on Raffles Medical Group (RMG) and lowering its target price by 12 cents to $1.25.

Broker's Calls

China Jinjiang Environment an opportunity to tap on fast-growing waste-to-energy market

SINGAPORE (May 26): CIMB Research remains upbeat on China Jinjiang Environment (CJE) amid robust growth in capacity expected ahead.
×